Breakthrough T1D's Inaugural Congress Spotlights Global T1D Research Advances

  • Breakthrough T1D concluded its inaugural Clinical & Research Congress (CRC 2026) in Philadelphia on October 11, 2026.
  • The event featured over 80 sessions covering endocrinology, immunotherapies, AI, and access to care for T1D patients.
  • CRC 2027 is scheduled for October 15-17, 2027, in Washington, D.C.
  • Breakthrough T1D aims to accelerate research and improve care for the 9.5 million people globally affected by T1D.

Breakthrough T1D's inaugural congress underscores the growing emphasis on collaborative research in the T1D space. The event highlights the organization's strategic shift from advocacy to a more research-driven approach, aligning with broader industry trends toward precision medicine and technological integration in healthcare. With 9.5 million people affected globally, the focus on access to care and treatment equity is critical.

Research Translation
How Breakthrough T1D will bridge the gap between scientific advances and clinical care.
Access to Care
Whether the organization can ensure new treatments reach all segments of the T1D community.
Technological Integration
The pace at which emerging technologies like AI and digital twins will impact T1D research.